Medisch  >  Lung Cancer Risk Rises With A1c, Falls With Medication

Lung Cancer Risk Rises With A1c, Falls With Medication

Researchers published the study covered in this summary on Preprints with The Lancet as a preprint that has not yet been peer reviewed.

Results from a large database study has shown a positive association between prediabetes, diabetes, and incident lung cancer.

Treatment with glucose-lowering medications was significantly linked with a reduced rate of incident lung cancer.

The relationship between incident lung cancer and A1c was nonlinear with the strongest associations occurring at A1c levels of 32-42 mmol/mol (5.1%-6.0%), levels that fall short of the cutoff for a diagnosis of diabetes, and at the lower end, fall short of the definition of prediabetes.

Wilt u de rest van dit artikel lezen?

Registreer gratis om toegang te krijgen tot de volledige inhoud van MediQuality op al uw schermen

Om veiligheidsredenen is uw browser niet compatibel met onze site

We raden u aan een van de volgende browsers te gebruiken: